News

24/04/2026

The Lancet Commission on Sepsis Launches Its Work With the Participation of Dr. Otavio Ranzani

Despite advances lately, sepsis remains one of the leading causes of mortality worldwide, and its management faces significant clinical and scientific limitations. In this context, The Lancet has laun...

22/04/2026

A Study Identifies New Genetic Factors That Modulate the Severity of SYNGAP1 Encephalopathy

A multicenter study with participation from the Institut de Recerca Sant Pau (IR Sant Pau) has delved deeper into the genetic mechanisms of encephalopathy associated with the SYNGAP1 gene. This rare d...

15/04/2026

A José Castillejo Program Grant Will Advance New Therapeutic Targets in Alzheimer’s Disease

Dr. Sònia Sirisi Dolcet, a researcher in the Neurobiology of Dementia group at the Institut de Recerca Sant Pau (IR Sant Pau), has been awarded a grant from the José Castillejo international mobilit...

10/04/2026

Biomarkers, Advanced Therapies, and New Targets Drive Change in Parkinson’s Research

Parkinson’s disease is the second most common neurodegenerative disorder and affects more than 160,000 people in Spain, with an estimated prevalence of between 20,000 and 25,000 patients in Cataloni...

10/04/2026

Ischemic Heart Disease in Women Presents Distinct Features That Shape Diagnosis, Treatment, and Prognosis

Despite advances in cardiology, women continue to face significant disparities in the prevention, diagnosis, and treatment of ischemic heart disease—a condition caused by reduced blood flow to cardi...